A) The balance of synaptic excitation and inhibition B) Only synaptic inhibition C) Only synaptic excitation D) The release of calcium ions
A) By enhancing inhibition or reducing excitation B) By completely blocking all neuronal signals C) By increasing excitation only D) By destroying motor neurons
A) By blocking acetylcholine receptors B) By mimicking or enhancing endogenous inhibitory substances like GABA C) By depleting GABA levels in the brain D) By increasing dopamine production
A) Exclusively in peripheral nerves B) Only at the neuromuscular junction C) Cortex, brain stem, or spinal cord D) Only in cardiac muscle tissue
A) Because they only act on the spinal cord B) Because they do not affect the nervous system at all C) Not every agent in this class has CNS activity, such as dantrolene D) Because they all act exclusively on peripheral muscles
A) As an antidepressant B) As a centrally acting muscle relaxant C) As a non-steroidal anti-inflammatory drug D) As a purely peripheral agent
A) As a centrally acting agent B) As a narcotic C) As a directly acting agent D) As an anticonvulsant
A) Antipyretic B) Spasmolytic C) Anesthetic D) Analgesic
A) Ibuprofen B) Paracetamol C) Carisoprodol D) Aspirin
A) Cyclobenzaprine B) Baclofen C) Diazepam D) Dantrolene
A) Hypertension B) Asthma C) Type 2 diabetes D) Fibromyalgia
A) Only for elderly patients B) No C) Only in severe cases D) Yes
A) Paracetamol or NSAIDs B) Antidepressants or anticonvulsants C) Antibiotics or antivirals D) Opioids or steroids
A) Opioids B) Antidepressants C) NSAIDs D) Barbiturates
A) Immunity to chronic pain B) Reduction in blood pressure C) Benefit to treatment with NSAIDs D) Complete cure for fibromyalgia
A) Definitive clinical trial evidence B) Robust high-quality evidence C) No high-quality evidence D) Extensive double-blind evidence
A) Yes, dantrolene is the least effective B) Yes, carisoprodol is superior to all others C) No drug has been shown to be better than another D) Yes, cyclobenzaprine is the most effective
A) Weight gain and hair loss B) Dizziness and drowsiness C) Insomnia and anxiety D) Hypertension and tachycardia
A) High risk of causing kidney failure B) Extreme financial cost of manufacturing C) Interference with digestive enzymes D) Possible abuse and interaction with other drugs
A) Brand name popularity and color B) Recommendation by the World Health Organization C) Adverse-effect profile, tolerability, and cost D) Speed of physical elimination
A) Neurological conditions such as spasticity B) Gastrointestinal conditions C) Cardiovascular conditions D) Orthopedic conditions
A) Parkinson's disease and Alzheimer's disease B) ALS and muscular dystrophy C) Cerebral palsy and multiple sclerosis D) Epilepsy and Huntington's disease
A) Gastrointestinal effects B) CNS effects C) Cardiovascular effects D) Renal effects
A) The neuromuscular junction B) The CNS C) Skeletal muscle tissue D) The peripheral nervous system
A) Lactic acid accumulation causes spasms B) Nerve compression directly triggers pain C) Pain induces spasm and spasm causes pain D) Muscle fibers tear during stress
A) Strong evidence proves this theory B) FDA studies have verified this theory C) Considerable evidence contradicts this theory D) Medical consensus fully accepts this theory
A) Orthopedic surgeons B) Rheumatologists C) Neurologists D) Cardiologists
A) To lower blood pressure B) To block pain receptors C) To prevent morning stiffness D) To increase stage 4 sleep
A) Patients feel more refreshed in the morning B) Patients heal broken bones faster C) Patients experience immediate weight loss D) Patients build muscle mass overnight
A) Metaxalone B) Tizanidine C) Dantrolene D) Baclofen
A) Baclofen and dantrolene B) Metaxalone and methocarbamol C) Diazepam and carisoprodol D) Cyclobenzaprine and tizanidine
A) Those with a history of high blood pressure B) Those with seasonal allergies C) Those with a history of drug or alcohol addiction D) Those with lactose intolerance
A) GABA B) Acetylcholine C) Serotonin D) Dopamine
A) Polarization B) Metabolism C) Excitation D) Inhibition
A) 1950 B) 1985 C) 2000 D) 1973
A) Low back pain B) Tension headaches C) Hypertension D) Fibromyalgia
A) Spasmolytics B) Beta-blockers C) Anticoagulants D) Diuretics
A) Increased muscle tone and strength. B) Enhanced neurological reflexes. C) Temporary paralysis. D) Permanent muscle relaxation.
A) Curare. B) Belladonna. C) Hemlock. D) Strychnine.
A) Morphine. B) Tubocurarine. C) Atropine. D) Cocaine.
A) Dopamine. B) Serotonin. C) Adrenaline. D) Acetylcholine.
A) 1977. B) 1943. C) 1959. D) 1962.
A) 1943. B) 1959. C) 1977. D) 1962.
A) August 1959. B) August 1943. C) August 1977. D) August 1962.
A) August 1959. B) August 1962. C) August 1985. D) August 1977.
A) Anticholinergic. B) Benzodiazepine. C) Opioid. D) Barbiturate.
A) Diazepam. B) Baclofen. C) Clonidine. D) Atropine.
A) Dantrolene. B) Tetrazepam. C) Chlorzoxazone. D) Metaxalone.
A) Methocarbamol. B) Aspirin. C) Ibuprofen. D) Penicillin.
A) Mephenoxalone. B) Lisinopril. C) Omeprazole. D) Paracetamol.
A) Cyclobenzaprine. B) Metaxalone. C) Meprobamate. D) Tizanidine.
A) Benzodiazepines. B) Anticholinergics. C) Methaqualone. D) Clonidine relatives.
A) Only in veterinary medicine. B) Yes. C) No. D) Only when combined with antibiotics.
A) Baclofen. B) Metaxalone. C) Equagesic. D) Dantrolene.
A) Fentanyl preparations. B) Tramadol tablets. C) Codeine syrups. D) Morphine patches.
A) Homeopathic opium dilutions. B) Topical opium creams. C) Synthetic opium isolates. D) Whole opium products.
A) Methadone. B) Ketobemidone. C) Oxycodone. D) Hydrocodone.
A) Potassium ions B) Sodium ions C) Calcium ions D) Chloride ions
A) Three B) Four C) Two D) One
A) Ca2+ B) Na+ C) K+ D) Mg2+
A) An acetylcholine esterase bridge B) A calcium ion bond C) A flexible sodium channel D) A rigid carbon ring system
A) Central nervous system B) Motor end plate C) Muscle membrane D) Skin epithelium
A) Endocytosis B) Diffusion C) Active transport D) Reverse polarization
A) Enzyme B) Agonist C) Antagonist D) Inhibitor
A) Kidney failure B) Permanent blindness C) Bone mineralization D) Dependence
A) Ryanodine receptors B) GABAB receptors C) GABAA receptors D) Alpha-2 adrenergic receptors
A) Decreased potassium ion conductance B) Increased sodium ion influx C) Decreased chloride ion transport D) Increased potassium ion conductance
A) It stops all electrical activity in the muscle fiber B) It depresses excitatory feedback from muscles C) It increases excitatory feedback from muscles D) It enhances calcium release from the sarcoplasmic reticulum
A) Extracellular fluid B) Sarcoplasmic reticulum C) Cell nucleus D) Mitochondria
A) Ryanodine receptor channel B) Glycine receptor channel C) GABAA receptor channel D) Alpha-2 adrenergic receptor channel
A) They are depressed only slightly B) They are unaffected C) They are stimulated to contract faster D) They are completely paralyzed
A) Insomnia B) Sedation C) Hyperactivity D) Muscle spasms
A) Hair loss B) Weight gain C) Increased appetite D) Dry mouth
A) High energy B) Improved hearing C) Blurred vision D) Rapid weight loss
A) Insomnia B) Extreme hunger C) Muscle growth D) Hallucinations
A) Temporary fatigue B) Mild drowsiness C) Severe allergic reactions D) Slight dry mouth |